Welcome, Guest. Please login or register.
July 17, 2024, 06:55:53 pm

Login with username, password and session length

  • Total Posts: 55130
  • Total Topics: 4851
  • Online Today: 219
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 41
Total: 41


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Researchers Make Progress in Developing Oral Hepatitis B Vaccine  (Read 8114 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Investigators have advanced their understanding of how to create an oral-delivery mechanism for the hepatitis B virus (HBV) vaccine. The injectable vaccine is relatively expensive, in part because of the complexities of its storage and transportation, since it must remain refrigerated. Consequently, the development of a cheaper, more easily transportable oral version would greatly facilitate the vaccine’s distribution in developing nations, where the need is great.

Publishing their findings in Scientific Reports, researchers studied how the HBV vaccine behaves when encapsulated in a material known as SBA-15. Previous research has indicated that SBA-15 is a promising form of encapsulation for the vaccine, likely able to help protect it against the digestive system and prevent it from being destroyed before it can impact the immune system.



© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.